From Big Data to Big Breakthroughs: Caleb Webber on Parkinson’s
Impossibile aggiungere al carrello
Puoi avere soltanto 50 titoli nel carrello per il checkout.
Riprova più tardi
Riprova più tardi
Rimozione dalla Lista desideri non riuscita.
Riprova più tardi
Non è stato possibile aggiungere il titolo alla Libreria
Per favore riprova
Non è stato possibile seguire il Podcast
Per favore riprova
Esecuzione del comando Non seguire più non riuscita
From Big Data to Big Breakthroughs: Caleb Webber on Parkinson’s
-
Letto da:
-
Di:
A proposito di questo titolo
Caleb is the Director of Informatics at the UK Dementia Research Institute and a leading voice in decoding the complexities of neurodegenerative disease. He reveals groundbreaking findings from his team’s work: surprising overlaps between Parkinson’s and diabetes, the discovery that existing hypertension medications may halve the risk of developing Parkinson’s, and a major new study exploring whether combining blood-pressure drugs with GLP-1 therapies (like Ozempic-type medications) could slow or even prevent the disease.
Caleb offers real reasons for optimism: that prevention may be within reach, that repurposed medications could help people sooner than expected, and that the next decade of brain-health research looks more promising than any before.
This is an episode filled with science, humanity, and genuine hope — for people living with Parkinson’s today, for those caring for them, and for anyone navigating life touched by neurodegenerative disease.
We'd love to hear your stories and your advice for anyone living with dementia - or if you have any questions for Justine and Prof Julie. Email us hello@twomindspodcast.co.uk.
For further help and advice please visit
https://www.alzheimers.org.uk
Ancora nessuna recensione